(1S,3aS,3bS,9aR,9bS,11aS)-N,N-diethyl-9a,11a-dimethyl-7-oxo-5-propyl-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[i]phenanthridine-1-carboxamide

ID: ALA1762035

Chembl Id: CHEMBL1762035

PubChem CID: 10251245

Max Phase: Preclinical

Molecular Formula: C26H42N2O2

Molecular Weight: 414.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN1C[C@H]2[C@@H]3CC[C@H](C(=O)N(CC)CC)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12

Standard InChI:  InChI=1S/C26H42N2O2/c1-6-15-28-17-19-20-9-10-22(24(30)27(7-2)8-3)25(20,4)14-12-21(19)26(5)13-11-18(29)16-23(26)28/h16,19-22H,6-15,17H2,1-5H3/t19-,20-,21-,22+,25-,26+/m0/s1

Standard InChI Key:  OCZSFVBWWMYLHE-XOZDTIMBSA-N

Associated Targets(Human)

SRD5A2 Tclin Steroid 5-alpha-reductase 2 (937 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 414.63Molecular Weight (Monoisotopic): 414.3246AlogP: 4.89#Rotatable Bonds: 5
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.82CX LogP: 3.94CX LogD: 3.94
Aromatic Rings: Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: 0.73

References

1. Thomas ST, Yang X, Sampson NS..  (2011)  Inhibition of the M. tuberculosis 3β-hydroxysteroid dehydrogenase by azasteroids.,  21  (8): [PMID:21439822] [10.1016/j.bmcl.2011.03.004]
2. Kumar R, Kumar M.  (2013)  3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5-reductase inhibitors,  22  (1): [10.1007/s00044-012-0006-1]

Source